Global Monoclonal Antibody Therapy Market Research Report 2023

Report ID: 1988676 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Monoclonal Antibody Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Human Monoclonal Antibody
        1.2.3 Humanized Monoclonal Antibody
        1.2.4 Chimeric Monoclonal Antibody
        1.2.5 Murine Monoclonal Antibody
    1.3 Market by Application
        1.3.1 Global Monoclonal Antibody Therapy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Autoimmune Diseases
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Monoclonal Antibody Therapy Market Perspective (2017-2028)
    2.2 Monoclonal Antibody Therapy Growth Trends by Region
        2.2.1 Monoclonal Antibody Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Monoclonal Antibody Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Monoclonal Antibody Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Monoclonal Antibody Therapy Market Dynamics
        2.3.1 Monoclonal Antibody Therapy Industry Trends
        2.3.2 Monoclonal Antibody Therapy Market Drivers
        2.3.3 Monoclonal Antibody Therapy Market Challenges
        2.3.4 Monoclonal Antibody Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Monoclonal Antibody Therapy Players by Revenue
        3.1.1 Global Top Monoclonal Antibody Therapy Players by Revenue (2017-2022)
        3.1.2 Global Monoclonal Antibody Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Monoclonal Antibody Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Monoclonal Antibody Therapy Revenue
    3.4 Global Monoclonal Antibody Therapy Market Concentration Ratio
        3.4.1 Global Monoclonal Antibody Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapy Revenue in 2021
    3.5 Monoclonal Antibody Therapy Key Players Head office and Area Served
    3.6 Key Players Monoclonal Antibody Therapy Product Solution and Service
    3.7 Date of Enter into Monoclonal Antibody Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Therapy Breakdown Data by Type
    4.1 Global Monoclonal Antibody Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Type (2023-2028)
5 Monoclonal Antibody Therapy Breakdown Data by Application
    5.1 Global Monoclonal Antibody Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Monoclonal Antibody Therapy Market Size (2017-2028)
    6.2 North America Monoclonal Antibody Therapy Market Size by Country (2017-2022)
    6.3 North America Monoclonal Antibody Therapy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Monoclonal Antibody Therapy Market Size (2017-2028)
    7.2 Europe Monoclonal Antibody Therapy Market Size by Country (2017-2022)
    7.3 Europe Monoclonal Antibody Therapy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Monoclonal Antibody Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Monoclonal Antibody Therapy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Monoclonal Antibody Therapy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Monoclonal Antibody Therapy Market Size (2017-2028)
    9.2 Latin America Monoclonal Antibody Therapy Market Size by Country (2017-2022)
    9.3 Latin America Monoclonal Antibody Therapy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Monoclonal Antibody Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Monoclonal Antibody Therapy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Monoclonal Antibody Therapy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbvie
        11.1.1 Abbvie Company Detail
        11.1.2 Abbvie Business Overview
        11.1.3 Abbvie Monoclonal Antibody Therapy Introduction
        11.1.4 Abbvie Revenue in Monoclonal Antibody Therapy Business (2017-2022)
        11.1.5 Abbvie Recent Development
    11.2 Amgen
        11.2.1 Amgen Company Detail
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Monoclonal Antibody Therapy Introduction
        11.2.4 Amgen Revenue in Monoclonal Antibody Therapy Business (2017-2022)
        11.2.5 Amgen Recent Development
    11.3 Glaxosmithkline
        11.3.1 Glaxosmithkline Company Detail
        11.3.2 Glaxosmithkline Business Overview
        11.3.3 Glaxosmithkline Monoclonal Antibody Therapy Introduction
        11.3.4 Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2017-2022)
        11.3.5 Glaxosmithkline Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Monoclonal Antibody Therapy Introduction
        11.4.4 Merck Revenue in Monoclonal Antibody Therapy Business (2017-2022)
        11.4.5 Merck Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Detail
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Monoclonal Antibody Therapy Introduction
        11.5.4 Novartis Revenue in Monoclonal Antibody Therapy Business (2017-2022)
        11.5.5 Novartis Recent Development
    11.6 Roche
        11.6.1 Roche Company Detail
        11.6.2 Roche Business Overview
        11.6.3 Roche Monoclonal Antibody Therapy Introduction
        11.6.4 Roche Revenue in Monoclonal Antibody Therapy Business (2017-2022)
        11.6.5 Roche Recent Development
    11.7 Johson & Johson
        11.7.1 Johson & Johson Company Detail
        11.7.2 Johson & Johson Business Overview
        11.7.3 Johson & Johson Monoclonal Antibody Therapy Introduction
        11.7.4 Johson & Johson Revenue in Monoclonal Antibody Therapy Business (2017-2022)
        11.7.5 Johson & Johson Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Monoclonal Antibody Therapy Introduction
        11.8.4 Novartis Revenue in Monoclonal Antibody Therapy Business (2017-2022)
        11.8.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Monoclonal Antibody Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Human Monoclonal Antibody
    Table 3. Key Players of Humanized Monoclonal Antibody
    Table 4. Key Players of Chimeric Monoclonal Antibody
    Table 5. Key Players of Murine Monoclonal Antibody
    Table 6. Global Monoclonal Antibody Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Monoclonal Antibody Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Monoclonal Antibody Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Monoclonal Antibody Therapy Market Share by Region (2017-2022)
    Table 10. Global Monoclonal Antibody Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Monoclonal Antibody Therapy Market Share by Region (2023-2028)
    Table 12. Monoclonal Antibody Therapy Market Trends
    Table 13. Monoclonal Antibody Therapy Market Drivers
    Table 14. Monoclonal Antibody Therapy Market Challenges
    Table 15. Monoclonal Antibody Therapy Market Restraints
    Table 16. Global Monoclonal Antibody Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Monoclonal Antibody Therapy Market Share by Players (2017-2022)
    Table 18. Global Top Monoclonal Antibody Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapy as of 2021)
    Table 19. Ranking of Global Top Monoclonal Antibody Therapy Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Monoclonal Antibody Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Monoclonal Antibody Therapy Product Solution and Service
    Table 23. Date of Enter into Monoclonal Antibody Therapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Monoclonal Antibody Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Monoclonal Antibody Therapy Revenue Market Share by Type (2017-2022)
    Table 27. Global Monoclonal Antibody Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Monoclonal Antibody Therapy Revenue Market Share by Type (2023-2028)
    Table 29. Global Monoclonal Antibody Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Monoclonal Antibody Therapy Revenue Market Share by Application (2017-2022)
    Table 31. Global Monoclonal Antibody Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Monoclonal Antibody Therapy Revenue Market Share by Application (2023-2028)
    Table 33. North America Monoclonal Antibody Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Monoclonal Antibody Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Monoclonal Antibody Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Monoclonal Antibody Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Monoclonal Antibody Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Monoclonal Antibody Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Monoclonal Antibody Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Monoclonal Antibody Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Monoclonal Antibody Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Monoclonal Antibody Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Abbvie Company Detail
    Table 44. Abbvie Business Overview
    Table 45. Abbvie Monoclonal Antibody Therapy Product
    Table 46. Abbvie Revenue in Monoclonal Antibody Therapy Business (2017-2022) & (US$ Million)
    Table 47. Abbvie Recent Development
    Table 48. Amgen Company Detail
    Table 49. Amgen Business Overview
    Table 50. Amgen Monoclonal Antibody Therapy Product
    Table 51. Amgen Revenue in Monoclonal Antibody Therapy Business (2017-2022) & (US$ Million)
    Table 52. Amgen Recent Development
    Table 53. Glaxosmithkline Company Detail
    Table 54. Glaxosmithkline Business Overview
    Table 55. Glaxosmithkline Monoclonal Antibody Therapy Product
    Table 56. Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2017-2022) & (US$ Million)
    Table 57. Glaxosmithkline Recent Development
    Table 58. Merck Company Detail
    Table 59. Merck Business Overview
    Table 60. Merck Monoclonal Antibody Therapy Product
    Table 61. Merck Revenue in Monoclonal Antibody Therapy Business (2017-2022) & (US$ Million)
    Table 62. Merck Recent Development
    Table 63. Novartis Company Detail
    Table 64. Novartis Business Overview
    Table 65. Novartis Monoclonal Antibody Therapy Product
    Table 66. Novartis Revenue in Monoclonal Antibody Therapy Business (2017-2022) & (US$ Million)
    Table 67. Novartis Recent Development
    Table 68. Roche Company Detail
    Table 69. Roche Business Overview
    Table 70. Roche Monoclonal Antibody Therapy Product
    Table 71. Roche Revenue in Monoclonal Antibody Therapy Business (2017-2022) & (US$ Million)
    Table 72. Roche Recent Development
    Table 73. Johson & Johson Company Detail
    Table 74. Johson & Johson Business Overview
    Table 75. Johson & Johson Monoclonal Antibody Therapy Product
    Table 76. Johson & Johson Revenue in Monoclonal Antibody Therapy Business (2017-2022) & (US$ Million)
    Table 77. Johson & Johson Recent Development
    Table 78. Novartis Company Detail
    Table 79. Novartis Business Overview
    Table 80. Novartis Monoclonal Antibody Therapy Product
    Table 81. Novartis Revenue in Monoclonal Antibody Therapy Business (2017-2022) & (US$ Million)
    Table 82. Novartis Recent Development
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Monoclonal Antibody Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Human Monoclonal Antibody Features
    Figure 3. Humanized Monoclonal Antibody Features
    Figure 4. Chimeric Monoclonal Antibody Features
    Figure 5. Murine Monoclonal Antibody Features
    Figure 6. Global Monoclonal Antibody Therapy Market Share by Application in 2021 & 2028
    Figure 7. Cancer Case Studies
    Figure 8. Autoimmune Diseases Case Studies
    Figure 9. Others Case Studies
    Figure 10. Monoclonal Antibody Therapy Report Years Considered
    Figure 11. Global Monoclonal Antibody Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Monoclonal Antibody Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Monoclonal Antibody Therapy Market Share by Region: 2021 VS 2028
    Figure 14. Global Monoclonal Antibody Therapy Market Share by Players in 2021
    Figure 15. Global Top Monoclonal Antibody Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapy as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapy Revenue in 2021
    Figure 17. North America Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Monoclonal Antibody Therapy Market Share by Country (2017-2028)
    Figure 19. United States Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Monoclonal Antibody Therapy Market Share by Country (2017-2028)
    Figure 23. Germany Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Monoclonal Antibody Therapy Market Share by Region (2017-2028)
    Figure 31. China Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Monoclonal Antibody Therapy Market Share by Country (2017-2028)
    Figure 39. Mexico Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Monoclonal Antibody Therapy Market Share by Country (2017-2028)
    Figure 43. Turkey Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Monoclonal Antibody Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Abbvie Revenue Growth Rate in Monoclonal Antibody Therapy Business (2017-2022)
    Figure 46. Amgen Revenue Growth Rate in Monoclonal Antibody Therapy Business (2017-2022)
    Figure 47. Glaxosmithkline Revenue Growth Rate in Monoclonal Antibody Therapy Business (2017-2022)
    Figure 48. Merck Revenue Growth Rate in Monoclonal Antibody Therapy Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Monoclonal Antibody Therapy Business (2017-2022)
    Figure 50. Roche Revenue Growth Rate in Monoclonal Antibody Therapy Business (2017-2022)
    Figure 51. Johson & Johson Revenue Growth Rate in Monoclonal Antibody Therapy Business (2017-2022)
    Figure 52. Novartis Revenue Growth Rate in Monoclonal Antibody Therapy Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis
Roche
Johson & Johson
Novartis
Frequently Asked Questions
Monoclonal Antibody Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Monoclonal Antibody Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Monoclonal Antibody Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Mucormycosis

Mucormycosis market is segmented by players, region (country), by Diagnosis and by Application. P ... Read More

Multimedia Chipset

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More